Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: epinephrine

Summary for Generic Name: epinephrine

Drug Master File Entries: see list10
Suppliers: see list10
Therapeutic Class:Respiratory Tract Agents

Pharmacology for Ingredient: epinephrine

Clinical Trials for: epinephrine

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine
Status: Completed Condition: Anaphylaxis

Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
Status: Recruiting Condition: Cardiopulmonary Arrest; Cardiac Arrest

Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
Status: Completed Condition: Asthma

Make up for the Epinephrine Autoinjector
Status: Completed Condition: Anaphylaxis

Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext
Status: Completed Condition: Handling of Auto-injectors

The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine
Status: Completed Condition: Spinal Anesthesia

The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
Status: Not yet recruiting Condition: Croup; Epinephrine Neublizer Treatment

Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
Status: Completed Condition: Adrenal Insufficiency

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Status: Completed Condition: Asthma; Bronchospasm; Wheezing; Shortness of Breath

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Status: Completed Condition: Adrenal Gland Neoplasms

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AEROSOL, METERED;INHALATION016803Approved Prior to Jan 1, 1982DISCNNo<disabled>
Armstrong Pharms
AEROSOL, METERED;INHALATION087907May 23, 1984DISCNNo<disabled>
Wyeth Cons
AEROSOL, METERED;INHALATION016126Approved Prior to Jan 1, 1982DISCNNo<disabled>
Forest Labs
INJECTABLE;INJECTION007942Feb 5, 1999DISCNNo<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology